Skip to content

Sector to Attain $6.27 Billion by 2028 at a 9.1% CAGR

DUBLIN, Jan 22, 2023 /PRNewswire/ — The “World Viscosupplementation Market, Measurement, World Forecast 2023-2028, Business Tendencies, Development, Affect of Inflation, Alternative Firm Evaluation” report has been added to’s providing.

Analysis and Markets Emblem

World Viscosupplementation Market is predicted to succeed in $6.27 Billion by 2028 in line with the writer. Sufferers with osteoarthritis have a minimally invasive therapeutic choice known as viscosupplementation.

Throughout viscosupplementation, hyaluronic acid is pushed into the joints. The synovial fluid that covers joints accommodates hyaluronic acid, a substance that happens naturally. It lubricates joints to permit bones to maneuver freely and fewer discomfort. Hyaluronic acid ranges within the joints are decrease in these with osteoarthritis, which causes ache.

Based on the analysis findings, Worldwide Viscosupplementation market was $3.71 Billion in 2022.

World Viscosupplementation Market will develop with 9.14% CAGR throughout the forecast interval:

The rise within the incidence of osteoarthritis, the rise within the geriatric inhabitants, and the hike within the variety of product launches and product approvals are the principle components driving the expansion of the worldwide viscosupplementation market measurement. Some of the prevalent varieties of arthritis is osteoarthritis.

In 2019, the Facilities for Illness Management and Prevention estimated that 32.5 million Individuals (1 in 7 adults) had osteoarthritis. As a consequence of a rise in power illnesses like weight problems, diabetes, and coronary heart illness, the prevalence of osteoarthritis has reached alarming ranges. Moreover, an absence of bodily exercise, resembling train, will increase the requirement for osteoarthritis therapy for the knee and hip and propels market growth.

Single Injection Viscosupplementation holds the lion’s share

By process, the Viscosupplementation market is split into three segments, ie, Single Injection Viscosupplementation, Three Injection Viscosupplementation, and 5 Injections Viscosupplementation. Amongst all, Single Injection dominates the present viscosupplementation market. The demand for outpatient surgical procedures that provide same-day surgical care, together with preventive (surgical) and diagnostic procedures, is driving the Single Injections Phase. Moreover, a rise in product launches and concentrate on creating single injections for the therapy of osteoarthritis are anticipated to contribute to the numerous development of the single-injection market over the forecast interval.

By Utility: The Knee Osteoarthritis Phase dominates the Market Share

As a result of elevated prevalence of knee osteoarthritis and the rising geriatric inhabitants, who’re extra susceptible to knee osteoarthritis, the knee osteoarthritis section dominated the Viscosupplementation market and is anticipated to keep up this development over the projected interval. As well as, the ageing impact, which reduces the quantity of water in cartilage and additional reduces its capability to soak up shock and cushion, makes the aged inhabitants extra vulnerable to creating knee osteoarthritis.

Orthopedic clinics/Ambulatory Surgical Facilities Phase is rising at a Important Development Charge

By Finish customers, the Viscosupplementation market is segmented into Hospitals and Orthopedic clinics/Ambulatory Surgical Facilities. Outpatient service websites, notably people who present ambulatory surgical procedure and doctor office-based therapies, have grown into fierce opponents for hospitals as a result of latest adoption of value-based care. Orthopedic clinics/Ambulatory Surgical Facilities provide each sensible and monetary advantages, resembling faster affected person entry, extra reasonably priced costs, extra alternatives for doctor involvement, and outpatient amenities. Therefore they purchase a dominant market share within the Viscosupplementation market.

By Area: North America and Asia Pacific holds a Important Market Share

North America occupies a dominant place within the international viscosupplementation market. The components contributing to the expansion of viscosupplementation within the North American area are the elevated prevalence of osteoarthritis and associated therapies, the ageing inhabitants, the well-established healthcare system, and the rising need for non-surgical procedures. Moreover, Asia Pacific is predicted to develop with a outstanding development charge throughout the forecast interval as a result of enhance within the geriatric inhabitants and rising healthcare expenditures.

Market Segmentation


1. Single Injection Viscosupplementation
2.Three Injections Viscosupplementation
3. 5 Injections Viscosupplementation


1.Knee Osteoarthritis
2.Hip Osteoarthritis
3. Hand/Wrist Osteoarthritis
4. Ankle/Foot Osteoarthritis

Finish Consumer

2. Orthopedic clinics/Ambulatory Surgical Facilities


one. North America
2. Europe
3. Asia Pacific
4. Remainder of World

Key Gamers

1. Anika Therapeutics Inc.
2. Sanofi
3.Zimmer Biomet
4.Smith & Nephew PLC
5.Lifecore Biomedical
6. LG Life Sciences Ltd.
7. F. Hoffmann-La Roche Ltd.
8. Chugai Pharmaceutical Co.

Key Subjects Coated:


2.Analysis & Methodology

3.Government Abstract

4.Market Dynamics

5. World Viscosupplementation Market

6. Market Share – World Viscosupplementation Evaluation

7. Product – World Viscosupplementation Market

8. Utility – World Viscosupplementation Market

9. Finish Consumer – World Viscosupplementation Market

10. Area – World Viscosupplementation Market

11.Firm Evaluation

For extra details about this report go to is the world’s main supply for worldwide market analysis studies and market information. We offer you the most recent information on worldwide and regional markets, key industries, the highest corporations, new merchandise and the most recent traits.

Media Contact:

Analysis and Markets
Laura WoodenSenior Supervisor

For EST Workplace Hours Name +1-917-300-0470
For US/CAN Toll Free Name +1-800-526-8630
For GMT Workplace Hours Name +353-1-416-8900

US Fax: 646-607-1907
Fax (outdoors US): +353-1-481-1716


cut up

View authentic content material: 1-cagr-301727320.html

SOURCE Analysis and Markets

Leave a Reply

Your email address will not be published. Required fields are marked *